Anti-Cd40 Antibodies and Uses Thereof
Copyright © Targeted News Service 2024
2024-04-09
ALEXANDRIA, Virginia, April 9 -- CYTOMX THERAPEUTICS, INC., South San Francisco, California has been assigned a patent (No. US 11952427 B2, initially filed March 15, 2022) developed by six inventors Bryan C. Barnhart, San Francisco, California; Brigitte Devaux, Palo Alto, California; Aaron P. Yamniuk, Lawrenceville, New Jersey; Shannon L. Okada, Seattle, Washington; Brenda L. Stevens, Seattle, Washington; and James William West, South San Francisco, California, for "Anti-CD40 antibodies and use . . .